ScienceDaily (Sep. 23, 2008) -- Extended treatment with Alzheimer's disease drugs can significantly slow the rate at which the disorder advances, and combination therapy with two different classes of READ MORE http://www.sciencedaily.com/releases/2008/09/08092...
March 3, 2009. Memantine is marketed for moderate-to-severe Alzheimer's, but two recent studies suggest it is effective for all stages of the disease when used in combination with any one of the olde READ MORE http://online.wsj.com/article/SB123603689949914421...
